PodParley PodParley

Season 5 / Ep. 4 (April 2025) - Amplifying Youth Voices and Engagement

Episode 4 of the United for Impact - Stories of Change, Progress, and the People Making it Happen podcast, hosted by United Way of Delaware, titled "Season 5 / Ep. 4 (April 2025) - Amplifying Youth Voices and Engagement" was published on April 30, 2025 and runs 26 minutes.

April 30, 2025 ·26m · United for Impact - Stories of Change, Progress, and the People Making it Happen

0:00 / 0:00

On this month's podcast, Michelle Taylor, President and CEO of United Way of Delaware leads a conversation with Kenny Norwood and Mitchell Brenner, 2 interns at United Way of Delaware, about youth voice and empowerment, civic engagement and leadership, adult engagement and support, and their personal growth and experience working at United Way. United Way of Delaware brings together people, organizations, and resources to address the challenges caused by long-standing disparities. In partners...

On this month's podcast, Michelle Taylor, President and CEO of United Way of Delaware leads a conversation with Kenny Norwood and Mitchell Brenner, 2 interns at United Way of Delaware, about youth voice and empowerment, civic engagement and leadership, adult engagement and support, and their personal growth and experience working at United Way.

United Way of Delaware brings together people, organizations, and resources to address the challenges caused by long-standing disparities. In partnership with passionate community leaders, we are dedicated to creating opportunities that empower men, women, and children across Delaware and Salem County, New Jersey. Our mission is to help families move from crisis to thriving, ensuring every child gets a strong start by reading at grade level. We are committed to equipping the next generation with the skills they need to become the workforce our state needs to flourish, while also ensuring families have access to livable wages that support their success and stability. Together, we’re building a stronger, more vibrant future for all.

Support the show

Founder's Focus Gary Beach For more than 25 years, TECH CORPS has worked to ensure K through 12th grade students in the United States have equal access to technology programs, skills and resources that enhance early learning and prepare them for college or career.Founder’s Focus invites you along for the journey as we examine technology and how it impacts the way we work and live. Agenda 559 Podcast Agenda 559 Our mission is to unite, educate and inspire our communities, provide insight, opportunity and conversations that will impact the world in positive, constructive manner. Agenda 559 stands as an outlet for people and talents of the Central Valley to be heard and expressed. Together we can build a better tomorrow. Support this podcast: https://anchor.fm/thaddis-johnson-jr/support SCREAM with Ryan C. Showers SCREAM with Ryan C. Showers "SCREAM with Ryan C. Showers" is podcast show that explores the Scream film franchise in deep, focused analysis. It is the goal of this show to unite the engaging, film critic analysis with a fan's passion and love for the mythology of Scream. This podcast aims to give equal airtime to Scream (1996), Scream 2, Scream 3, Scream 4, Scream (2022), Scream 6, and the upcoming Scream 7, as well as Scream-adjacent topics. Episode coverage will include character development, storylines, themes, symbolism, filmmaking techniques and craftsmanship, the horror genre, cinematic legacies, comparative discussions, and cultural impacts. In addition, "SCREAM with Ryan C. Showers" will provide coverage and discourse of news about upcoming installments in the movie series. Exploring Best Practices for Diagnosis & Management of Adult-Onset Still's Disease AOSD Podcast Adult-onset Still’s disease (AOSD) is a rare, polygenic autoinflammatory syndrome with a pathogenesis similar to systemic juvenile inflammatory arthritis. Join Drs. Petros Efthimiou and Olga Petryna as they discuss making the diagnosis of AOSD through interpretation of clinical and laboratory findings and careful exclusion of other diseases. The faculty review the evidence related to the variety of medications often used to treat patients with AOSD, focusing on canakinumab, the only medication approved in the United States for the disease.
URL copied to clipboard!